These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33851144)

  • 1. Understanding vaccine hesitancy in COVID-19.
    Trogen B; Pirofski LA
    Med; 2021 May; 2(5):498-501. PubMed ID: 33851144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
    Levin J; Bradshaw M
    BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination Hesitancy and Conspiracy Beliefs in the UK During the SARS-COV-2 (COVID-19) Pandemic.
    Bacon AM; Taylor S
    Int J Behav Med; 2022 Aug; 29(4):448-455. PubMed ID: 34599463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
    Carcelen AC; Prosperi C; Mutembo S; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Chilumba I; Musukwa G; Thuma P; Kapungu K; Hamahuwa M; Mutale I; Winter A; Moss WJ; Truelove SA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34227914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis.
    Truong J; Bakshi S; Wasim A; Ahmad M; Majid U
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34244738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective.
    Gerussi V; Peghin M; Palese A; De Martino M; Graziano E; Chiappinotto S; Fonda F; Bontempo G; Semenzin T; Martini L; Isola M; Tascini C
    Hum Vaccin Immunother; 2024 Dec; 20(1):2358565. PubMed ID: 38825984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trust of Italian healthcare professionals in COVID-19 (anti-SARS-COV-2) vaccination.
    Di Valerio Z; Montalti M; Guaraldi F; Tedesco D; Nreu B; Mannucci E; Monami M; Gori D
    Ann Ig; 2022; 34(3):217-226. PubMed ID: 34328496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.
    Parimi K; Gilkeson K; Creamer BA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2062972. PubMed ID: 35436173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
    Ameratunga R
    Expert Rev Vaccines; 2022 Sep; 21(9):1177-1184. PubMed ID: 35695410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the increasing vaccination model and the moderating roles of chronic medical conditions and education to understand COVID-19 vaccination uptake in Singapore.
    Chen XK; Ong J; Neo LS; Tan LF
    Transl Behav Med; 2023 Jul; 13(7):453-464. PubMed ID: 37084298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and Behaviours towards Immunisation Programmes: Vaccine Hesitancy during the COVID-19 Pandemic Era.
    Dettori M; Arghittu A; Castiglia P
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs.
    Qunaibi EA; Helmy M; Basheti I; Sultan I
    Elife; 2021 May; 10():. PubMed ID: 34042047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic.
    Harapan H; Anwar S; Yufika A; Sharun K; Gachabayov M; Fahriani M; Husnah M; Raad R; Abdalla RY; Adam RY; Khiri NM; Ismaeil MI; Ismail AY; Kacem W; Dahman NB; Teyeb Z; Aloui K; Hafsi M; Ferjani M; Deeb DA; Emad D; Abbas KS; Monib FA; Sami FS; Subramaniam R; Panchawagh S; Anandu S; Haque MA; Ferreto LE; Briones MF; Morales RB; Díaz SA; Aburto JT; Rojas JE; Balogun EO; Enitan SS; Yomi AR; Durosinmi A; Ezigbo ED; Adejumo EN; Babadi E; Kakemam E; Malik NI; Ullah I; Rosiello DF; Emran TB; Wendt GW; Arab-Zozani M; Wagner AL; Mudatsir M
    Pathog Glob Health; 2022 Jun; 116(4):236-243. PubMed ID: 34928187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
    Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
    Front Public Health; 2021; 9():728690. PubMed ID: 34900890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes.
    Piekos SN; Price ND; Hood L; Hadlock JJ
    Reprod Toxicol; 2022 Dec; 114():33-43. PubMed ID: 36283657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic.
    Ouyang H; Ma X; Wu X
    Hum Vaccin Immunother; 2022 Dec; 18(1):2013694. PubMed ID: 35172676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia.
    Zammit N; Gueder AE; Brahem A; Ayouni I; Ghammam R; Fredj SB; Sridi C; Chouchene A; Kalboussi H; Maalel OE; Chatti S; Maatoug J; Ghannem H; Mrizak N
    BMC Health Serv Res; 2022 Apr; 22(1):489. PubMed ID: 35413911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
    Pitts PJ; Poland GA
    Vaccine; 2024 May; 42(13):3145-3147. PubMed ID: 38604913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.